CTDP1
Basic information
Region (hg38): 18:79679803-79754503
Links
Phenotypes
GenCC
Source:
- congenital cataracts-facial dysmorphism-neuropathy syndrome (Definitive), mode of inheritance: AR
- congenital cataracts-facial dysmorphism-neuropathy syndrome (Supportive), mode of inheritance: AR
- congenital cataracts-facial dysmorphism-neuropathy syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Congenital cataracts, facial dysmorphism, and neuropathy | AR | Endocrine; Pharmacogenomic; Renal | In Hypogonadotropic hypogonadism, surveillance in adolescence related to sexual maturation is indicated, as is monitoring of bone mineral density in order to allow early detection and treatment of disease; In the instance of anesthesia, monitoring is indicated, (eg, for severe complications such as stridor, pulmonary edema, malignant hyperthermia, and seizures); Individuals may suffer severe rhabdomyolysis related to viral infections, and awareness may allow rapid management | Cardiovascular; Endocrine; Musculoskeletal; Neurologic; Ophthalmologic; Renal | 10439962; 10360766; 10442556; 14517542; 16194727; 16939648; 20301787; 21824574 |
ClinVar
This is a list of variants' phenotypes submitted to
- Congenital cataracts-facial dysmorphism-neuropathy syndrome (1 variants)
- Charcot-Marie-Tooth disease (1 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CTDP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 125 | 17 | 144 | |||
missense | 181 | 22 | 212 | |||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 6 | 14 | 6 | 26 | ||
non coding | 82 | 39 | 123 | |||
Total | 1 | 0 | 192 | 229 | 66 |
Variants in CTDP1
This is a list of pathogenic ClinVar variants found in the CTDP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-79679844-G-T | Benign (Jun 29, 2018) | |||
18-79679899-G-C | Likely benign (Nov 02, 2020) | |||
18-79679914-C-T | Likely benign (May 17, 2019) | |||
18-79679943-C-T | CTDP1-related disorder | Likely benign (Oct 29, 2021) | ||
18-79679953-G-A | Likely benign (Jan 15, 2024) | |||
18-79679953-G-T | Uncertain significance (Mar 18, 2022) | |||
18-79679961-C-A | Benign (Jan 22, 2024) | |||
18-79679961-C-T | Uncertain significance (Jul 30, 2022) | |||
18-79679974-T-G | Likely benign (Sep 05, 2023) | |||
18-79679975-C-T | Uncertain significance (Oct 13, 2022) | |||
18-79679981-G-C | Uncertain significance (Feb 09, 2022) | |||
18-79679989-C-T | Likely benign (May 03, 2022) | |||
18-79679990-C-T | not specified | Uncertain significance (Feb 13, 2024) | ||
18-79679992-G-A | Likely benign (Apr 24, 2023) | |||
18-79679993-A-C | Uncertain significance (Mar 04, 2022) | |||
18-79679995-G-A | Likely benign (Mar 01, 2023) | |||
18-79679998-G-A | Likely benign (Dec 22, 2023) | |||
18-79680005-G-A | Uncertain significance (Jun 05, 2024) | |||
18-79680005-G-T | Uncertain significance (Feb 09, 2022) | |||
18-79680007-C-T | Likely benign (Sep 08, 2023) | |||
18-79680018-G-T | not specified | Uncertain significance (Jul 25, 2023) | ||
18-79680020-C-T | Uncertain significance (Jul 29, 2022) | |||
18-79680024-G-A | not specified | Uncertain significance (Aug 30, 2023) | ||
18-79680025-G-C | Likely benign (Jan 18, 2024) | |||
18-79680028-C-G | Likely benign (Feb 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CTDP1 | protein_coding | protein_coding | ENST00000299543 | 13 | 74710 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000600 | 0.999 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.996 | 501 | 568 | 0.882 | 0.0000403 | 6141 |
Missense in Polyphen | 171 | 249.17 | 0.68626 | 2750 | ||
Synonymous | -1.50 | 293 | 262 | 1.12 | 0.0000220 | 1950 |
Loss of Function | 3.86 | 13 | 39.0 | 0.333 | 0.00000237 | 432 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000867 | 0.0000867 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.0000807 | 0.0000791 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Processively dephosphorylates 'Ser-2' and 'Ser-5' of the heptad repeats YSPTSPS in the C-terminal domain of the largest RNA polymerase II subunit. This promotes the activity of RNA polymerase II. Plays a role in the exit from mitosis by dephosphorylating crucial mitotic substrates (USP44, CDC20 and WEE1) that are required for M-phase-promoting factor (MPF)/CDK1 inactivation. {ECO:0000269|PubMed:22692537}.;
- Disease
- DISEASE: Congenital cataracts, facial dysmorphism, and neuropathy (CCFDN) [MIM:604168]: An autosomal recessive developmental disorder characterized by a complex clinical phenotype with seemingly unrelated features involving multiple organs and systems. Developmental abnormalities include congenital cataracts and microcorneae, hypomyelination of the peripheral nervous system, impaired physical growth, delayed early motor and intellectual development, facial dysmorphism and hypogonadism. Central nervous system involvement, with cerebral and spinal cord atrophy, may be the result of disrupted development with superimposed degenerative changes. Affected individuals are prone to severe rhabdomyolysis after viral infections and to serious complications related to general anesthesia (such as pulmonary edema and epileptic seizures). {ECO:0000269|PubMed:14517542}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Disease;Formation of the HIV-1 Early Elongation Complex;Gene expression (Transcription);Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;Abortive elongation of HIV-1 transcript in the absence of Tat;HIV Transcription Elongation;HIV elongation arrest and recovery;Formation of HIV elongation complex in the absence of HIV Tat;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Tat-mediated HIV elongation arrest and recovery;Pausing and recovery of Tat-mediated HIV elongation;Transcription of the HIV genome;Late Phase of HIV Life Cycle;HIV Life Cycle;HIV Infection;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex ;RNA Polymerase II Transcription;Infectious disease;RNA Polymerase II Transcription Elongation;TP53 Regulates Transcription of DNA Repair Genes;Transcriptional Regulation by TP53;Formation of the Early Elongation Complex
(Consensus)
Recessive Scores
- pRec
- 0.230
Intolerance Scores
- loftool
- 0.251
- rvis_EVS
- -0.84
- rvis_percentile_EVS
- 11.48
Haploinsufficiency Scores
- pHI
- 0.118
- hipred
- Y
- hipred_score
- 0.749
- ghis
- 0.543
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.955
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ctdp1
- Phenotype
Zebrafish Information Network
- Gene name
- ctdp1
- Affected structure
- head
- Phenotype tag
- abnormal
- Phenotype quality
- pointed
Gene ontology
- Biological process
- transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;protein dephosphorylation;exit from mitosis;positive regulation by host of viral transcription;cell division;negative regulation of cell growth involved in cardiac muscle cell development;dephosphorylation of RNA polymerase II C-terminal domain
- Cellular component
- spindle pole;nucleus;nucleoplasm;cytoplasm;centrosome;spindle;midbody;protein-containing complex;intracellular membrane-bounded organelle;spindle midzone
- Molecular function
- TFIIF-class transcription factor complex binding;phosphoprotein phosphatase activity;protein binding;RNA polymerase II CTD heptapeptide repeat phosphatase activity;Tat protein binding